CLCE23LF

Situation: Exeltis has been focused on the creation and research of new drugs that help society. This year we have been focused, above all, on being recognized for being the company that thinks about the health and well-being of women.

Brief: Relaunch our product: an estrogen-free contraceptive pill and to inform people about our communication focused on the inclusion of women and being the company that thinks about the health and well-being of women.

Objetives: Acquisition of potential new clients and repositioning of our brand.

More than 5,000 inserts delivered.

More than 30,000 people reached.

More than 2 Million social impressions.

100% positive sentiment on social media and the streets.

In Chile, only 6% of women who enter university choose a career in science, a context that responds to a global problem, but which in Chile is exacerbated by the lack of incentives to counteract this, in addition to the cost that is higher education in this country

The lack of female representation in the field of science is a big problem as it reduces the capacity for innovation and protection of women’s health.

An example of this are contraceptive pills, wich have a huge number of side effects. Without going any further, only men participated in its creation.

This is how now, these pills have an enormous number of side effects resulting in a package insert that is even bigger than a newspaper page.

For the launch of our new estrogen-free pill with fewer side effects, in which male and female scientists worked together... we collected hundreds of package inserts

In Chile, the purchase of contraceptive pills is free and does not require a medical pre-registration.

Women in general, but with a strong emphasis on young university students who are pursuing scientific careers, this is because they are mainly the ones who can reduce the gender gap in science in the near future